期刊文献+

MicroRNA-196a抑制序列对人胰腺癌PANC1细胞株HOXB8基因表达的影响 被引量:1

Effects of microRNA-196a inhibitory sequences on HOXB8 expression in human pancreatic cancerPANC1 cells
原文传递
导出
摘要 目的观察microRNA-196a(miR-196a)抑制序列转染胰腺癌细胞株PANC1后对其HOXB8基因表达的影响。方法将PANC1细胞分为对照组、miR-196a抑制序列组和siRNA对照组。采用脂质体法将miR-196a抑制序列及对照siRNA分别转染PANC1细胞。应用RT—PCR和蛋白质印迹法检测转染细胞miR-196a及其下游靶基因HOXB8mRNA和蛋白的表达。结果转染miR-196a抑制序列后,PANC1细胞miR-196a表达量较siRNA对照组显著减少(0.050±0.054比0.839±0.025。t=3.12,P〈0.05);HOXB8mRNA表达量较siRNA对照组增高1.57倍(2.20±0.07比1.29±0.10,t=3.86,P〈0.05);HOXB8蛋白表达量也显著增强(0.90±0.03比0.40±0.10,t=3.11,P〈0.05)。结论miR-196a可以下调HOXB8基因的表达。 Objective To investigate the effects of microRNA-196a(miR-196a) inhibitory sequences transfection on HOXB8 expression in PANC1 cells. Methods PANC1 cells were divided into control group, miR-196a inhibitory sequences group and siRNA control group. Liposomal transfection method was applied to transfect miR 196a inhibitory sequences and siRNA control into PANC1 cells. RT-PCR and Western blot were used to detect the expressions of miR-196a and HOXB8 mRNA and protein. Results After miR-196a inhibitory sequences transfeetion, when compared with that of siRNA control group, the expression of miR-196a was significantly decreased (0.05 ± 0. 054 vs. 0. 839 ± 0. 025, t = 3.12, P 〈0.05 ) ; and the expression of HOXB8 mRNA was significantly increased by 1.57 folds (2.20± 0.07 vs. 1.29± 0.10, t = 3.86, P 〈 0.05 ), the expression of HOXB8 protein was also obviously increased (0.90 ± 0. 03 vs. 0. 40 ± 0.10, t = 3.11, P 〈 0.05 ). Conclusions MicroRNA-196a down-regulates the expression of HOXB8.
出处 《中华胰腺病杂志》 CAS 2013年第1期13-15,共3页 Chinese Journal of Pancreatology
基金 国家自然基金面上项目(30971344) 上海市科委基础研究重点项目(11JC1416402)
关键词 胰腺肿瘤 微小RNA miR-196a HOXB8 Pancreatic neoplasms MicroRNA MicroRNA-196a HOXB8
  • 相关文献

参考文献1

二级参考文献32

  • 1Weir HK,Thun MJ,Hankey BF,Ries LA,Howe HL,Wingo PA,Jemal A,Ward E,Anderson RN,Edwards BK.Annual report to the nation on the status of cancer,1975-2000,featuring the uses of surveillance data for cancer prevention and control.J Natl Cancer Inst 2003; 95:1276-1299
  • 2Greenlee RT,Murray T,Bolden S,Wingo PA.Cancer statistics,2000.CA Cancer J Clin 2000; 50:7-33
  • 3August DA,Ottow RT,Sugarbaker PH.Clinical perspective of human colorectal cancer metastasis.Cancer Metastasis Rev 1984; 3:303-324
  • 4Fearon ER,Vogelstein B.A genetic model for colorectal tumorigenesis.Cell 1990; 61:759-767
  • 5Cho KR,Vogelstein B.Genetic alterations in the adenoma--carcinoma sequence.Cancer 1992; 70:1727-1731
  • 6Vogelstein B,Kinzler KW.The multistep nature of cancer.Trends Genet 1993; 9:138-141
  • 7Smith G,Carey FA,Beattie J,Wilkie MJ,Lightfoot TJ,Coxhead J,Garner RC,Steele RJ,Wolf CR.Mutations in APC,Kirsten-ras,and p53--alternative genetic pathways to colorectal cancer.Proc Natl Acad Sci USA 2002; 99:9433-9438
  • 8Ambros V.microRNAs:tiny regulators with great potential.Cell 2001; 107:823-826
  • 9Bartel DP.MicroRNAs:genomics,biogenesis,mechanism,and function.Cell 2004; 116:281-297
  • 10Carrington JC,Ambros V.Role of microRNAs in plant and animal development.Science 2003; 301:336-338

共引文献40

同被引文献4

引证文献1

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部